Us Bancorp \De\ Halozyme Therapeutics, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 34,740 shares of HALO stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,740

Previous 16,501 110.53%

Holding current value

$1.65 Million

Previous $863,000 130.24%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$51.3 - $64.42 $935,660 - $1.17 Million	18,239 Added 110.53%	34,740 $1.99 Million
Q2 2024 Aug 06, 2024	BUY	$37.81 - $52.4 $97,890 - $135,663	2,589 Added 18.61%	16,501 $863,000
Q1 2024 May 07, 2024	BUY	$33.68 - $41.95 $183,825 - $228,963	5,458 Added 64.56%	13,912 $565,000
Q4 2023 Feb 09, 2024	SELL	$33.32 - $42.1 $6,930 - $8,756	-208 Reduced 2.4%	8,454 $312,000
Q3 2023 Nov 03, 2023	BUY	$36.46 - $44.03 $6,380 - $7,705	175 Added 2.06%	8,662 $330,000
Q2 2023 Aug 09, 2023	SELL	$30.28 - $38.74 $5,632 - $7,205	-186 Reduced 2.14%	8,487 $306,000
Q1 2023 May 09, 2023	SELL	$32.86 - $55.7 $44,361 - $75,195	-1,350 Reduced 13.47%	8,673 $331,000
Q4 2022 Feb 13, 2023	SELL	$40.06 - $59.44 $51,356 - $76,202	-1,282 Reduced 11.34%	10,023 $570,000
Q3 2022 Oct 27, 2022	BUY	$38.53 - $51.78 $9,093 - $12,220	236 Added 2.13%	11,305 $447,000
Q2 2022 Aug 01, 2022	SELL	$37.35 - $48.3 $59,535 - $76,990	-1,594 Reduced 12.59%	11,069 $487,000
Q1 2022 May 11, 2022	BUY	$31.97 - $41.06 $123,372 - $158,450	3,859 Added 43.83%	12,663 $506,000
Q4 2021 Feb 11, 2022	SELL	$31.82 - $40.75 $66,949 - $85,738	-2,104 Reduced 19.29%	8,804 $354,000
Q3 2021 Nov 10, 2021	SELL	$38.47 - $46.42 $49,280 - $59,464	-1,281 Reduced 10.51%	10,908 $444,000
Q2 2021 Aug 05, 2021	SELL	$38.84 - $51.31 $29,557 - $39,046	-761 Reduced 5.88%	12,189 $553,000
Q1 2021 Apr 28, 2021	BUY	$39.51 - $51.45 $109,640 - $142,773	2,775 Added 27.27%	12,950 $540,000
Q4 2020 Feb 04, 2021	BUY	$25.81 - $43.62 $44,573 - $75,331	1,727 Added 20.44%	10,175 $434,000
Q2 2020 Aug 07, 2020	BUY	$16.25 - $26.81 $14,511 - $23,941	893 Added 11.82%	8,448 $226,000
Q1 2020 May 13, 2020	BUY	$13.9 - $21.83 $34,291 - $53,854	2,467 Added 48.49%	7,555 $136,000
Q4 2019 Feb 04, 2020	BUY	$14.93 - $19.53 $15,571 - $20,369	1,043 Added 25.78%	5,088 $90,000
Q3 2019 Nov 08, 2019	SELL	$15.2 - $17.69 $71,683 - $83,426	-4,716 Reduced 53.83%	4,045 $63,000
Q2 2019 Aug 13, 2019	BUY	$14.75 - $17.26 $4,159 - $4,867	282 Added 3.33%	8,761 $150,000
Q1 2019 May 08, 2019	BUY	$13.94 - $17.58 $3,777 - $4,764	271 Added 3.3%	8,479 $136,000
Q4 2018 Feb 13, 2019	BUY	$13.33 - $18.66 $15,409 - $21,570	1,156 Added 16.39%	8,208 $120,000
Q3 2018 Nov 01, 2018	BUY	$16.68 - $18.41 $50,156 - $55,358	3,007 Added 74.34%	7,052 $128,000
Q3 2017 Nov 13, 2017	BUY	$11.76 - $17.4 $47,569 - $70,383	4,045	4,045 $70,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account